Phase
Condition
N/ATreatment
Whole Genome Sequencing
Clinical Study ID
Ages 1-120 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Aim 1-
- Diagnosis of Hypophosphatasia based on clinical features that include
History consistent with diagnosis of hypophosphatasia AND
Physical examination findings consistent with a diagnosis of hypophosphatasiaAND
Presence of low serum alkaline phosphatase level for age and sex AND
Elevation of at least one natural substrate of alkaline phosphatase
- Lack of detection of a variant on molecular analysis of the ALPL gene. Whenpossible, first degree relatives (parents, siblings, or child) will be included forthe sole purpose of trio testing. No additional information will be collected onfirst degree relatives.
Aim 2-
Missense variant in ALPL which is interpreted as a variant of uncertain significanceby the American College of Medical Genetics Guidelines for Variant Interpretation
Variant has been interpreted as pathogenic, likely pathogenic, likely benign, orbenign using ex-US interpretation guidelines
Exclusion
Exclusion Criteria:
Aim 1-
History and physical examination incompatible with a diagnosis of hypophosphatasiaOR
Absence of hypophosphatasemia as measured by age and sex-matched control OR
Absence of at least one elevated natural substrate of alkaline phosphatase OR
Alternate diagnosis which could overlap with signs and symptoms of hypophosphatasia
Aim 2-
- Inability to express variant in plasmid for residual enzyme and co-transfectionanalyses
Study Design
Study Description
Connect with a study center
Children's Mercy Hospital
Kansas City, Missouri 64108
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.